The 4P's Plus© screen for substance use in pregnancy: Clinical application and outcomes

Journal of Perinatology

Volumn 25, Issue 6, 2005, Pages 368-374

  Chasnoff, Ira J ^a   McGourty, Richard F ^a   Bailey, Gregory W ^a   Hutchins, Ellen ^b   Lightfoot, Saundra O ^c   Pawson, Leslie Lyn ^d   Fahey, Cynthia ^e   May, Barbara ^f   Brodie, Paula ^g   McCulley, Larry ^g   Campbell, Jan ^h  

^a Children's Research Triangle   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d VENTURA COUNTY MEDICAL CENTER   (United States)

^e Public Works for Ventura County   (United States)

^f Southern New Jersey Perinatal Coalition   (United States)

^g Southern Illinois Healthcare Foundation   (United States)

^h San Luis Obispo County Public Health Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC TEST; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; INTERVIEW; MASS SCREENING; MATERNAL CARE; MATERNAL WELFARE; POPULATION DISTRIBUTION; POPULATION RESEARCH; PREGNANCY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE;

ALCOHOL DRINKING; FEMALE; HUMANS; INTERVIEWS; PREGNANCY; PRENATAL CARE; SMOKING; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 20844435810     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211266     Document Type: Article

References (30)

1. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med 1985;313:666-9.
2. Shiono PH, Klebanoff MA, Nugent RP, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol 1995;72:19-27.
3. Armstrong MA, Osejo VG, Lieberman L, Carpenter DM, Pantoja PM, Escobar GJ. Perinatal substance abuse intervention in obstetric clinics decreases adverse neonatal outcomes. J Perinatol 2003;23:3-9.
4. Frank DA, Bauchner H, Parker S, et al. Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana. J Pediatr 1990;117:622-6.
5. Chasnoff IJ, Anson A, Hatcher R, Stenson H, Iaukea K, Randolph L. Prenatal exposure to cocaine and other drugs: outcome at four to six years. In: Harvey JA, Kosofsky BE, editors. Cocaine Effects On the Developing Brain. New York, NY: Annals of the New York Academy of Science; 1998. p. 314-28.
6. Fried PA, Watkinson B. 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol. Dev Behav Pediat 1990;11(2):49-58.
7. Wekselman K, Spiering K, Hetteberg C, Kenner C, Flandermeyer A. Fetal alcohol syndrome from infancy through childhood: a review of the literature. J Pediatr Nurs 1995;10(5):296-303.
8. Sood B, Delaney-Black V, Covington C, et al. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. Dose-response effect. Pediatrics 2001;108(e34):1-9.
9. Morse B, Gehshan S, Hutchins E. Screening for substance abuse during pregnancy: improving care, improving health. National Center for Education in Maternal and Child Health. 1997.
10. Chasnoff IJ. Psychosocial Issues in Pregnancy. Washington, DC: American College of Obstetrics and Gynecology; 2002.
11. Ewing J. Detecting alcoholism: the CAGE questionnaire. JAMA 1984;252: 1905-7.
12. Kitchens JM. Does this patient have an alcohol problem? JAMA 1994;272: 1782-7.
13. Bottoms SF, Martier SS, Sokol RJ. Refinements in screening for risk drinking in reproductive-aged women: the "NET" results. Alcoholism 1989;13:339.
14. Sokol RJ, Martier SS, Ager JW. The T-AGE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol 1989;160:863-8.
15. Russsell M, Martier SS, Sokol RJ, et al. Screening for pregnancy risk-drinking: TWEAKing the tests. Alcsm Clin Exp Res 1991;15:368 abstract no. 338.
16. Russell M, Martier SS, Sokol RJ, et al. Screening for pregnancy risk-drinking. Alcsm Clin Exp Res 1994;18:1156-61.
17. Chan AW, Pristach EA, Welte JW, Russell M. Use of the TWEAK test in screening for alcoholism/heavy drinking in three populations. Alcsm Clin Exp Res 1993;17:1188-92.
18. Howell E, Heiser N, Thornton C, Moreno L, Chasnoff IJ, Hill I. Third Annual Report: Evaluation of the Demonstration to Improve Access to Care for Pregnant Substance Abusers. Washington, DC: Mathematica Policy Research; 1996.
19. Chasnoff IJ, Hung WC. The 4P's Plus. Chicago: NTI Publishing; 1999.
20. Chasnoff IJ, Neuman K, Thornton C, Callaghan MA. Screening for substance use in pregnancy: a practical approach for the primary care physician. Am J Obstet Gynecol 2001;184:752-8.
21. Chasnoff IJ, Hutchins E. Motivating Providers to Screen for Alcohol Use in Pregnancy. Philadelphia, PA: American Public Health Association; 2002.
22. Johnson BT. DSTAT: Software for the Meta-Analytic Review of Research Literatures. Hillsdale, NJ: Lawrence Erlbaum Associates; 1989.
23. National Institute on Drug Abuse. National Pregnancy and Health Survey: Drug Use among women Delivering Live Births: 1992. Rockville, MD: US Department of Health and Human Services; 1996.
24. Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of drug or alcohol use during pregnancy and discrepancies in mandory reporting in Pinellas County, Florida. N Engl J Med 1990;322:1202-6.
25. Clark CM, Li DC, Conry J, Loock R. Structural and functional brain integrity of Fetal Alcohol Syndrome in Nonretarded Cases. Pediatrics 2000; 105:1096-9.
26. Larrson G. Prevention of fetal alcohol effects: an antenatal program for early detection of pregnancies at risk. Acta Obstet Gynecol Scand 1983;62: 171-8.
27. Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy: perinatal outcome. JAMA 1989; 261(12):1741-4.
28. Perl Harold I. Numerous studies demonstrate effectiveness of brief interventions. Frontlines, November NIAAA, 2000.
29. U.S. Preventive Services Task Force Ratings: Strength of Recommendations and Quality of Evidence. Guide to Clinical Preventive Services, Third Edition: Periodic Updates, 2000-2003. Rockville, MD: Agency for Healthcare Research and Quality; http://www.ahrq.gov/clinic/3rduspstf/ratings.htm.
30. ACOG Committee on Ethics. At-risk drinking and illicit drug use: Ethical issues in obstetric and gynecotogic practice. ACOG Committee Opinion No. 294. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;103:1021-31.